5N Plus (TSX:VNP) ROCE % : 7.56% (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is 5N Plus ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. 5N Plus's annualized ROCE % for the quarter that ended in Dec. 2024 was 7.56%.

5N Plus ROCE % Historical Data

The historical data trend for 5N Plus's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

5N Plus ROCE % Chart

5N Plus Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

5.51

4.99

-4.45

9.88

11.52

5N Plus Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															5.53	10.92	12.24	12.49	7.56

5N Plus ROCE % Calculation

5N Plus's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	46.697	/	( ( (469.831 - 109.752)	+	(536.979 - 86.167) )	/ 2 )
	=	46.697	/	( (360.079	+	450.812)	/ 2 )
	=	46.697	/	405.4455
	=	11.52 %

5N Plus's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	33.436	/	( ( (515.1 - 80.838)	+	(536.979 - 86.167) )	/ 2 )
	=	33.436	/	( ( 434.262	+	450.812 )	/ 2 )
	=	33.436	/	442.537
	=	7.56 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

5N Plus (TSX:VNP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

5N Plus ROCE % Related Terms

Thank you for viewing the detailed overview of 5N Plus's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

5N Plus Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » 5N Plus Inc (TSX:VNP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

FPLSF:USA EMB:Germany

Address

4385 Garand Street, Saint-Laurent, Montreal, QC, CAN, H4R 2B4

Website

https://www.5nplus.com

5N Plus Inc is a Canadian-based company producing specialty semiconductors and performance materials. It operates in two segments Specialty Semiconductors and Performance Materials. The Specialty Semiconductors segment manufactures and sells products used in several applications such as renewable energy, space satellites, and imaging. The Performance Materials segment manufactures and sells products that are used in several applications in pharmaceutical & healthcare, industrial, and catalytic and extractive. Main products are sold as active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial-grade metals, alloys, and engineered powders. The maximum revenue is derived from the Specialty Semiconductors segment.

Executives

Jean-marie Bourassa	Director
Richard Perron	Senior Officer
Luc Bertrand	Director
Jurgen Heizmann	Senior Officer
Gervais Jacques	Director, Senior Officer
Arjang Roshan	Senior Officer
Nathalie Le Prohon	Director
Nicholas Audet	Senior Officer
Paul Tancell	Senior Officer
Jean Mayer	Senior Officer

5N Plus Headlines

No Headlines